Cyclosporin A in patients receiving renal allografts from cadaver donors.
about
Cyclosporin A associated helicase-like protein facilitates the association of hepatitis C virus RNA polymerase with its cellular cyclophilin BHistory of clinical transplantationTopical ciclosporin in the treatment of ocular surface disordersHistory of Nephrotic Syndrome and Evolution of its TreatmentEnigmatic insight into collagenCancers Related to Immunodeficiencies: Update and PerspectivesPharmacogenomics and personalized medicine: a review focused on their application in the Chinese populationCyclosporin A: a new drug in the field of canine dermatologyMycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolismOverview of clinical lung transplantationLaparoscopy in Liver Transplantation: The Future has ArrivedEfficacy of AZM therapy in patients with gingival overgrowth induced by Cyclosporine A: a systematic review.Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.Cardiac transplantation. Selection, immunosuppression, and survival.Mycophenolate mofetil--is it worth the cost? The in-favor opinion.Calcineurin downregulation in the amygdala is sufficient to induce anxiety-like and depression-like behaviors in C57BL/6J male mice.The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts.A clinical review of drug-induced gingival overgrowths.Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles.Cyclosporine immunosuppression and delayed graft function in 455 cadaveric renal transplantsEffects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients.Liver transplantation: current conceptsCurrent treatment practice in immunosuppression.Adverse effects associated with the use of FK 506Effect of cyclosporine on hepatic cytosolic estrogen and androgen receptor levels before and after partial hepatectomy.Current status of hepatic transplantation.Cyclosporin A hepatotoxicity in 66 renal allograft recipientsEffect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.Evolution of liver transplantation.Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntletGassericin A: a circular bacteriocin produced by lactic acid bacteria Lactobacillus gasseri.Causes of death after liver transplantation in children treated with cyclosporine and steroids.Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation.The hepatotropic influence of cyclosporine.The cadaveric kidney and the organ shortage--a perspective review.Steps in immunosuppression for renal transplantation.Liver and kidney transplantation in children receiving cyclosporin A and steroids.Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection.Cyclosporin A in cadaveric organ transplantationCadaveric Renal Transplantation in Diabetics in the 1980's: with Special Reference to Cyclosporine
P2860
Q21135500-62FA8E9D-8AFE-4264-82D4-D3858EE061ECQ24596303-EEA22CF1-DB31-455D-AF08-6600CD364E1AQ24670344-218607A6-18B2-4A8F-BD93-72E5AA55B041Q26745891-FE9054FC-FF85-4FA5-B86E-74B63DD6E386Q28070002-3393FCC3-6CF1-4077-A157-98647121BBC1Q28074182-CD088707-73CE-4BA4-B1EE-55ED3D307E79Q28083875-E4C1F973-4343-446E-AD09-5C71B5E0D8CDQ28251267-3339BC84-1F6F-42D5-B779-7D24E431D65EQ28539334-BC511CEE-EDD5-4214-BCDB-71D55912321EQ28661021-F2ADDD3B-3D7E-444A-8AA2-1C1D5B350BF2Q30485655-2DFB8A84-8D09-4228-8AFA-12AF524A9854Q33393482-002992CD-5330-452C-A534-E430C8E5F46CQ33480997-00CBC39F-4101-4958-9DA4-BDD48F0859BEQ33616485-06B46E23-BF1E-4FDC-B4A7-DD81D5A06B8DQ33652719-73158634-BC22-4CDB-A71E-91005AF8737EQ33680438-80310064-F0CB-41B2-8D2B-C7D8C18A4313Q33768650-8B501118-F330-417F-AE07-30B034C9DC12Q33844744-0BC31F67-A268-4FBB-A59B-A22632957E1EQ33930853-7BA08431-E45A-4474-B084-98112C543182Q33993493-8A716292-8ABA-43CB-BC51-CFA255D39BCDQ33999915-5F802014-B5F5-4192-B339-3192B3862262Q34101719-9CF2D88D-D5DC-493F-B211-56DAEB0B94EEQ34181796-3C1B1DC8-0F6B-45FC-BF48-4C538DC907D3Q34187736-F621D8B2-6F7A-45E7-8DD8-745198906D6DQ34198126-D558AF8E-9E24-4CF8-88EA-417962F122BAQ34207236-3C2983AF-A7E8-442A-825C-B7347243A1F9Q34232449-1DAFCDCD-0355-4BAA-A921-BDB9CE642C3EQ34240283-729619C8-86AC-434D-A9DC-26BA53C82510Q34275840-9E266601-0EAF-4A33-B846-32AA88165383Q34340969-CDAC18B0-2E28-43D2-B05A-D5ADB37B2027Q34347078-A54735D5-91F9-47D3-9AED-F194AF26C281Q34396804-2019C508-EFAC-4CB5-B74F-7492630D2D81Q34403351-4F73E65B-CA6B-40C8-BEA8-D47FDEF6ECD5Q34421473-3C84F9AA-93E3-46BB-9E40-90C775A95EDEQ34459162-FAEEF120-95C2-4EAE-8552-C9616AC065B4Q34497811-DB3A3E00-85F7-439C-B4B8-C87F15382B47Q34561587-1A03542A-0A06-430C-8944-C24042BD5EF7Q34607590-23190B3A-A7C1-4AC0-9C65-FB0EBC56469DQ34778331-23630F9D-F24C-48B3-8078-80C8EE0FE9CAQ34942321-34DA1577-84B5-4EA3-A30F-68F3D21BB55E
P2860
Cyclosporin A in patients receiving renal allografts from cadaver donors.
description
1978 nî lūn-bûn
@nan
1978 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@ast
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@en
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@nl
type
label
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@ast
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@en
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@nl
prefLabel
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@ast
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@en
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@nl
P2093
P1433
P1476
Cyclosporin A in patients receiving renal allografts from cadaver donors.
@en
P2093
B D Pentlow
G N Craddock
P McMaster
P304
P356
10.1016/S0140-6736(78)91970-0
P407
P433
P577
1978-12-01T00:00:00Z